Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis / prepared by Southern California/RAND Evidence-based Practice Center.
| Other author | Southern California Evidence-Based Practice Center/RAND. |
| Other author | United States. Agency for Healthcare Research and Quality. |
| Format | Electronic |
| Publication Info | [Rockville, Md.] : [Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services], [2004] |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS47369 |
| Subjects |
| Variant title | Effects of omega 3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis |
| Series | AHRQ publication ; no. 04-E 012-2 Evidence report/technology assessment ; no. 89 Evidence report/technology assessment ; no. 89. ^A480454 AHRQ publication ; no. 04-E 012-2. ^A457037 |
| General note | Title from title screen (viewed on Apr. 13, 2004). |
| Technical details | System requirements: ZIP decompression software; MS Word software. |
| Technical details | Mode of access: Internet from the AHRQ web site. Address as of 4/13/04: http://www.ahrq.gov/downloads/pub/evidence/o3lipids.zip; current access available via PURL. |
| GPO item number | 0491-B-31 (online) |
| Govt. docs number | HE 20.6524:89 |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |